June 25, 2010

Vaccine Aluminum Associated With Brain Damage

Do you think that this is a study that might should maybe have been brought to our attention last year by public health?

Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.

J Inorg Biochem. 2009 Nov;103(11):1571-8. Epub 2009 Aug 20.

Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ.

INSERM, Unite U955, Team 1, Creteil F-94010, France.
Abstract

Macrophagic myofasciitis (MMF) is an emerging condition, characterized by specific muscle lesions assessing long-term persistence of aluminum hydroxide within macrophages at the site of previous immunization. Affected patients mainly complain of arthromyalgias, chronic fatigue, and cognitive difficulties. We designed a comprehensive battery of neuropsychological tests to prospectively delineate MMF-associated cognitive dysfunction (MACD). Compared to control patients with arthritis and chronic pain, MMF patients had pronounced and specific cognitive impairment. MACD mainly affected (i) both visual and verbal memory; (ii) executive functions, including attention, working memory, and planning; and (iii) left ear extinction at dichotic listening test. Cognitive deficits did not correlate with pain, fatigue, depression, or disease duration. Pathophysiological mechanisms underlying MACD remain to be determined. In conclusion, long-term persistence of vaccine-derived aluminum hydroxide within the body assessed by MMF is associated with cognitive dysfunction, not solely due to chronic pain, fatigue and depression.

PMID: 19748679 [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

No comments: